Medindia LOGIN REGISTER
Medindia

Pentoxifylline Interaction with other Drugs


Pentoxifylline is a xanthine derivative, prescribed for intermittent claudication (pain, cramping, numbness, or weakness in the foot, hip, thigh, or buttocks) due to poor blood circulation.

Pentoxifylline Interaction with 279 drugs. Find out more in the list below:

3-N-Butylphthalide


Pentoxifylline may increase the antiplatelet activities of Butylphthalide.

Abciximab


Pentoxifylline may increase the antiplatelet activities of Abciximab.

Abiraterone


The serum concentration of Pentoxifylline can be increased when it is combined with Abiraterone.

Advertisement

Acebutolol


Pentoxifylline may increase the hypotensive activities of Acebutolol.

Acenocoumarol


Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.

Acetyl salicylate


Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid.

Advertisement

Aliskiren


Pentoxifylline may increase the hypotensive activities of Aliskiren.

Aloxiprin


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aloxiprin.

alpha Tocopherol


Vitamin E may increase the antiplatelet activities of Pentoxifylline.

Advertisement

Alprenolol


Pentoxifylline may increase the hypotensive activities of Alprenolol.

Alprostadil


Pentoxifylline may increase the antiplatelet activities of Alprostadil.

Alteplase


Pentoxifylline may increase the anticoagulant activities of Alteplase.

Ambrisentan


Pentoxifylline may increase the hypotensive activities of Ambrisentan.

AMBROXOL ACEFYLLINATE


The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Pentoxifylline.

Ambroxol-Theophylline-7-Acetate


The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Pentoxifylline.

Aminophylline


The serum concentration of Aminophylline can be increased when it is combined with Pentoxifylline.

Aminosalicylic Acid


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Aminosalicylic Acid.

Amlodipine


Pentoxifylline may increase the hypotensive activities of Amlodipine.

Anagrelide


Pentoxifylline may increase the antiplatelet activities of Anagrelide.

Ancrod


Pentoxifylline may increase the anticoagulant activities of Ancrod.

Anistreplase


Pentoxifylline may increase the anticoagulant activities of Anistreplase.

Antithrombin III


Pentoxifylline may increase the anticoagulant activities of Antithrombin III human.

Antithrombin III, Human


Pentoxifylline may increase the anticoagulant activities of Antithrombin III human.

Apixaban


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Apixaban.

Ardeparin


Pentoxifylline may increase the anticoagulant activities of Ardeparin.

Argatroban


Pentoxifylline may increase the antiplatelet activities of Argatroban.

Argatroban Anhydrous


Pentoxifylline may increase the antiplatelet activities of Argatroban.

Aspirin


Pentoxifylline may increase the antiplatelet activities of Acetylsalicylic acid.

Astaxanthin


Pentoxifylline may increase the anticoagulant activities of Astaxanthin.

Atenolol


Pentoxifylline may increase the hypotensive activities of Atenolol.

Azelastine


Pentoxifylline may increase the antiplatelet activities of Azelastine.

Azithromycin


The metabolism of Pentoxifylline can be decreased when combined with Azithromycin.

Balsalazide


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Balsalazide.

Becaplermin


Pentoxifylline may increase the anticoagulant activities of Becaplermin.

Bemiparin


Pentoxifylline may increase the anticoagulant activities of Bemiparin.

Benazepril


Pentoxifylline may increase the hypotensive activities of Benazepril.

Bendroflumethiazide


Pentoxifylline may increase the hypotensive activities of Bendroflumethiazide.

Bepridil


Pentoxifylline may increase the hypotensive activities of Bepridil.

Betaxolol


Pentoxifylline may increase the hypotensive activities of Betaxolol.

Bethanidine


Pentoxifylline may increase the hypotensive activities of Bethanidine.

Bimatoprost


Pentoxifylline may increase the hypotensive activities of Bimatoprost.

Bisoprolol


Pentoxifylline may increase the hypotensive activities of Bisoprolol.

Bivalirudin


Pentoxifylline may increase the anticoagulant activities of Bivalirudin.

Bortezomib


The metabolism of Pentoxifylline can be decreased when combined with Bortezomib.

Bosentan


Pentoxifylline may increase the hypotensive activities of Bosentan.

Bretylium


Pentoxifylline may increase the hypotensive activities of Bretylium.

Brimonidine


Pentoxifylline may increase the hypotensive activities of Brimonidine.

Bupranolol


Pentoxifylline may increase the hypotensive activities of Bupranolol.

Cafedrine


Pentoxifylline may increase the hypotensive activities of Cafedrine.

Caffeine


The metabolism of Pentoxifylline can be decreased when combined with Caffeine.

Candesartan


Pentoxifylline may increase the hypotensive activities of Candesartan.

Candesartan Cilexetil


Pentoxifylline may increase the hypotensive activities of Candesartan cilexetil.

Cangrelor


Pentoxifylline may increase the antiplatelet activities of Cangrelor.

Captopril


Pentoxifylline may increase the hypotensive activities of Captopril.

Carteolol


Pentoxifylline may increase the hypotensive activities of Carteolol.

Carvedilol


Pentoxifylline may increase the hypotensive activities of Carvedilol.

Celiprolol


Pentoxifylline may increase the hypotensive activities of Celiprolol.

Certoparin


Pentoxifylline may increase the anticoagulant activities of Certoparin.

Chlorothiazide


Pentoxifylline may increase the hypotensive activities of Chlorothiazide.

Chlorthalidone


Pentoxifylline may increase the hypotensive activities of Chlorthalidone.

Cicletanine


Pentoxifylline may increase the hypotensive activities of Cicletanine.

Cilazapril


Pentoxifylline may increase the hypotensive activities of Cilazapril.

Cilostazol


Pentoxifylline may increase the antiplatelet activities of Cilostazol.

Cimetidine


The serum concentration of Pentoxifylline can be increased when it is combined with Cimetidine.

Citalopram


The metabolism of Pentoxifylline can be decreased when combined with Citalopram.

Citric Acid


Pentoxifylline may increase the anticoagulant activities of Citric Acid.

Citric Acid, Anhydrous


Pentoxifylline may increase the anticoagulant activities of Citric Acid.

Clonidine


Pentoxifylline may increase the hypotensive activities of Clonidine.

Clopidogrel


Pentoxifylline may increase the antiplatelet activities of Clopidogrel.

Clotrimazole


The metabolism of Pentoxifylline can be decreased when combined with Clotrimazole.

COLLAGENASE


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Collagenase clostridium histolyticum.

collagenase Clostridium histolyticum


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Collagenase clostridium histolyticum.

Cryptenamine


Pentoxifylline may increase the hypotensive activities of Cryptenamine.

Cyclopenthiazide


Pentoxifylline may increase the hypotensive activities of Cyclopenthiazide.

Cyclothiazide


Pentoxifylline may increase the hypotensive activities of Cyclothiazide.

Cyproterone Acetate


The serum concentration of Pentoxifylline can be decreased when it is combined with Cyproterone acetate.

Dabigatran Etexilate


Pentoxifylline may increase the anticoagulant activities of Dabigatran etexilate.

Dalteparin


Pentoxifylline may increase the anticoagulant activities of Dalteparin.

Danaparoid


Pentoxifylline may increase the anticoagulant activities of Danaparoid.

Dasatinib


Dasatinib may increase the anticoagulant activities of Pentoxifylline.

Dasatinib Anhydrous


Dasatinib may increase the anticoagulant activities of Pentoxifylline.

Debrisoquin


Pentoxifylline may increase the hypotensive activities of Debrisoquin.

Deferasirox


The serum concentration of Pentoxifylline can be increased when it is combined with Deferasirox.

Defibrotide


Pentoxifylline may increase the antiplatelet activities of Defibrotide.

Deoxycholate


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic Acid.

Deoxycholic Acid


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Deoxycholic Acid.

Deserpidine


Pentoxifylline may increase the hypotensive activities of Deserpidine.

Desirudin


Pentoxifylline may increase the anticoagulant activities of Desirudin.

Dextran


Pentoxifylline may increase the anticoagulant activities of Dextran.

Dextran 40


Pentoxifylline may increase the anticoagulant activities of Dextran 40.

Dextran 70


Pentoxifylline may increase the anticoagulant activities of Dextran 70.

Dextran 75


Pentoxifylline may increase the anticoagulant activities of Dextran 75.

Diazoxide


Pentoxifylline may increase the hypotensive activities of Diazoxide.

Dicumarol


Pentoxifylline may increase the anticoagulant activities of Dicoumarol.

Diflunisal


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Diflunisal.

Dihydralazine


Pentoxifylline may increase the hypotensive activities of Dihydralazine.

Diltiazem


Pentoxifylline may increase the hypotensive activities of Diltiazem.

Dipyridamole


Pentoxifylline may increase the antiplatelet activities of Dipyridamole.

Dorzolamide


Pentoxifylline may increase the hypotensive activities of Dorzolamide.

Dothiepin


The serum concentration of Pentoxifylline can be increased when it is combined with Dosulepin.

Doxazosin


Pentoxifylline may increase the hypotensive activities of Doxazosin.

Drotrecogin Alfa


Pentoxifylline may increase the anticoagulant activities of Drotrecogin alfa.

Dyphylline


The serum concentration of Dyphylline can be increased when it is combined with Pentoxifylline.

Edetic Acid


Pentoxifylline may increase the anticoagulant activities of Edetic Acid.

Edoxaban


Pentoxifylline may increase the anticoagulant activities of Edoxaban.

Enalapril


Pentoxifylline may increase the hypotensive activities of Enalapril.

Enalaprilat


Pentoxifylline may increase the hypotensive activities of Enalaprilat.

Enalaprilat Anhydrous


Pentoxifylline may increase the hypotensive activities of Enalaprilat.

Enoxaparin


Pentoxifylline may increase the anticoagulant activities of Enoxaparin.

Enoxaparin sodium


Pentoxifylline may increase the anticoagulant activities of Enoxaparin.

Epinastine


Pentoxifylline may increase the antiplatelet activities of Epinastine.

Epoprostenol


Pentoxifylline may increase the antiplatelet activities of Epoprostenol.

Eprosartan


Pentoxifylline may increase the hypotensive activities of Eprosartan.

Eptifibatide


Pentoxifylline may increase the antiplatelet activities of Eptifibatide.

Ethylenediaminetetraacetate


Pentoxifylline may increase the anticoagulant activities of Edetic Acid.

Felodipine


Pentoxifylline may increase the hypotensive activities of Felodipine.

Fenoldopam


Pentoxifylline may increase the hypotensive activities of Fenoldopam.

Ferulic Acid


Pentoxifylline may increase the hypotensive activities of Ferulic acid.

Fluindione


Pentoxifylline may increase the anticoagulant activities of Fluindione.

Fluvoxamine


The serum concentration of Pentoxifylline can be increased when it is combined with Fluvoxamine.

Fondaparinux


Pentoxifylline may increase the anticoagulant activities of Fondaparinux.

Fondaparinux sodium


Pentoxifylline may increase the anticoagulant activities of Fondaparinux sodium.

Fosinopril


Pentoxifylline may increase the hypotensive activities of Fosinopril.

Glucosamine


Glucosamine may increase the antiplatelet activities of Pentoxifylline.

Guanabenz


Pentoxifylline may increase the hypotensive activities of Guanabenz.

Guanadrel


Pentoxifylline may increase the hypotensive activities of Guanadrel.

Guanethidine


Pentoxifylline may increase the hypotensive activities of Guanethidine.

Guanfacine


Pentoxifylline may increase the hypotensive activities of Guanfacine.

Heparin


Pentoxifylline may increase the anticoagulant activities of Heparin.

Hydralazine


Pentoxifylline may increase the hypotensive activities of Hydralazine.

Hydrochlorothiazide


Pentoxifylline may increase the hypotensive activities of Hydrochlorothiazide.

Hydroflumethiazide


Pentoxifylline may increase the hypotensive activities of Hydroflumethiazide.

Hydroxytyrosol


Pentoxifylline may increase the antiplatelet activities of Hydroxytyrosol.

Ibritumomab Tiuxetan


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Ibritumomab tiuxetan.

Ibrutinib


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Pentoxifylline.

Icosapent Ethyl


Pentoxifylline may increase the antiplatelet activities of Icosapent ethyl.

Ifenprodil


Pentoxifylline may increase the antiplatelet activities of Ifenprodil.

Iloprost


Pentoxifylline may increase the antiplatelet activities of Iloprost.

Imidapril


Pentoxifylline may increase the hypotensive activities of Imidapril.

Indapamide


Pentoxifylline may increase the hypotensive activities of Indapamide.

Indobufen


Pentoxifylline may increase the antiplatelet activities of Indobufen.

Indoramin


Pentoxifylline may increase the hypotensive activities of Indoramin.

Irbesartan


Pentoxifylline may increase the hypotensive activities of Irbesartan.

Isradipine


Pentoxifylline may increase the hypotensive activities of Isradipine.

Ketanserin


Pentoxifylline may increase the antiplatelet activities of Ketanserin.

Ketorolac


The risk or severity of adverse effects can be increased when Ketorolac is combined with Pentoxifylline.

Labetalol


Pentoxifylline may increase the hypotensive activities of Labetalol.

Lacidipine


Pentoxifylline may increase the hypotensive activities of Lacidipine.

Latanoprost


Pentoxifylline may increase the hypotensive activities of Latanoprost.

Lepirudin


Pentoxifylline may increase the anticoagulant activities of Lepirudin.

Lercanidipine


Pentoxifylline may increase the hypotensive activities of Lercanidipine.

Lidocaine


The metabolism of Pentoxifylline can be decreased when combined with Lidocaine.

Lisinopril


Pentoxifylline may increase the hypotensive activities of Lisinopril.

Lisinopril Anhydrous


Pentoxifylline may increase the hypotensive activities of Lisinopril.

Lofexidine


Pentoxifylline may increase the hypotensive activities of Lofexidine.

Losartan


Pentoxifylline may increase the hypotensive activities of Losartan.

Macitentan


Pentoxifylline may increase the hypotensive activities of Macitentan.

Manidipine


Pentoxifylline may increase the hypotensive activities of Manidipine.

Mecamylamine


Pentoxifylline may increase the hypotensive activities of Mecamylamine.

Mesalamine


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Mesalazine.

Methyl Salicylate


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Methyl salicylate.

Methyldopa


Pentoxifylline may increase the hypotensive activities of Methyldopa.

METHYLDOPA ANHYDROUS


Pentoxifylline may increase the hypotensive activities of Methyldopa.

Metipranolol


Pentoxifylline may increase the hypotensive activities of Metipranolol.

Metolazone


Pentoxifylline may increase the hypotensive activities of Metolazone.

Metoprolol


Pentoxifylline may increase the hypotensive activities of Metoprolol.

Metyrosine


Pentoxifylline may increase the hypotensive activities of Metyrosine.

Mexiletine


The serum concentration of Pentoxifylline can be increased when it is combined with Mexiletine.

Mibefradil


Pentoxifylline may increase the hypotensive activities of Mibefradil.

Midostaurin


The serum concentration of Pentoxifylline can be increased when it is combined with Midostaurin.

Milrinone


Pentoxifylline may increase the antiplatelet activities of Milrinone.

Minoxidil


Pentoxifylline may increase the hypotensive activities of Minoxidil.

Moexipril


Pentoxifylline may increase the hypotensive activities of Moexipril.

Moxonidine


Pentoxifylline may increase the hypotensive activities of Moxonidine.

Nadolol


Pentoxifylline may increase the hypotensive activities of Nadolol.

Nadroparin


Pentoxifylline may increase the anticoagulant activities of Nadroparin.

Nebivolol


Pentoxifylline may increase the hypotensive activities of Nebivolol.

Nevirapine


The metabolism of Pentoxifylline can be decreased when combined with Nevirapine.

Nicardipine


Pentoxifylline may increase the hypotensive activities of Nicardipine.

Nicorandil


Pentoxifylline may increase the hypotensive activities of Nicorandil.

Nilvadipine


Pentoxifylline may increase the hypotensive activities of Nilvadipine.

Nimesulide


Pentoxifylline may increase the antiplatelet activities of Nimesulide.

Nimodipine


Pentoxifylline may increase the hypotensive activities of Nimodipine.

Nisoldipine


Pentoxifylline may increase the hypotensive activities of Nisoldipine.

Nitrendipine


Pentoxifylline may increase the hypotensive activities of Nitrendipine.

Nitroprusside


Pentoxifylline may increase the hypotensive activities of Nitroprusside.

Obinutuzumab


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Obinutuzumab.

Olmesartan


Pentoxifylline may increase the hypotensive activities of Olmesartan.

Olsalazine


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Olsalazine.

Omega-3 Fatty Acids


Omega-3 fatty acids may increase the antiplatelet activities of Pentoxifylline.

Osimertinib


The serum concentration of Pentoxifylline can be decreased when it is combined with Osimertinib.

Oxprenolol


Pentoxifylline may increase the hypotensive activities of Oxprenolol.

Pargyline


Pentoxifylline may increase the hypotensive activities of Pargyline.

Parnaparin


Pentoxifylline may increase the anticoagulant activities of Parnaparin.

Peginterferon Alfa-2b


The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.

Penbutolol


Pentoxifylline may increase the hypotensive activities of Penbutolol.

Pentaerythritol Tetranitrate


Pentoxifylline may increase the anticoagulant activities of Pentaerythritol Tetranitrate.

Pentosan Polysulfate


The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Pentoxifylline.

Perindopril


Pentoxifylline may increase the hypotensive activities of Perindopril.

Phenindione


Pentoxifylline may increase the anticoagulant activities of Phenindione.

Phenoxybenzamine


Pentoxifylline may increase the hypotensive activities of Phenoxybenzamine.

Phenprocoumon


Pentoxifylline may increase the anticoagulant activities of Phenprocoumon.

Phentolamine


Pentoxifylline may increase the hypotensive activities of Phentolamine.

Phentolamine Mesylate


Pentoxifylline may increase the hypotensive activities of Phentolamine.

Phospholipids


Omega-3 fatty acids may increase the antiplatelet activities of Pentoxifylline.

Pinacidil


Pentoxifylline may increase the hypotensive activities of Pinacidil.

Pindolol


Pentoxifylline may increase the hypotensive activities of Pindolol.

Plasmin


Pentoxifylline may increase the anticoagulant activities of Fibrinolysin.

Polythiazide


Pentoxifylline may increase the hypotensive activities of Polythiazide.

Prasugrel


Pentoxifylline may increase the antiplatelet activities of Prasugrel.

Prazosin


Pentoxifylline may increase the hypotensive activities of Prazosin.

Propranolol


Pentoxifylline may increase the hypotensive activities of Propranolol.

protein C, human


Pentoxifylline may increase the anticoagulant activities of Protein C.

protein S, human


Pentoxifylline may increase the anticoagulant activities of Protein S human.

Protocatechualdehyde


Pentoxifylline may increase the anticoagulant activities of Protocatechualdehyde.

Quinapril


Pentoxifylline may increase the hypotensive activities of Quinapril.

Ramipril


Pentoxifylline may increase the hypotensive activities of Ramipril.

Rescinnamine


Pentoxifylline may increase the hypotensive activities of Rescinnamine.

Reserpine


Pentoxifylline may increase the hypotensive activities of Reserpine.

Resveratrol


Pentoxifylline may increase the antiplatelet activities of Resveratrol.

Reteplase


Pentoxifylline may increase the anticoagulant activities of Reteplase.

Reviparin


Pentoxifylline may increase the anticoagulant activities of Reviparin.

Reviparin sodium


Pentoxifylline may increase the anticoagulant activities of Reviparin.

Rilmenidine


Pentoxifylline may increase the hypotensive activities of Rilmenidine.

Riociguat


Pentoxifylline may increase the hypotensive activities of Riociguat.

Rivaroxaban


Pentoxifylline may increase the anticoagulant activities of Rivaroxaban.

Ropinirole


The metabolism of Pentoxifylline can be decreased when combined with Ropinirole.

Rosiglitazone


Pentoxifylline may increase the anticoagulant activities of Rosiglitazone.

Rucaparib


The metabolism of Pentoxifylline can be decreased when combined with Rucaparib.

Salicylic Acid


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Salicylic acid.

Selexipag


Pentoxifylline may increase the hypotensive activities of Selexipag.

Sevoflurane


Pentoxifylline may increase the antiplatelet activities of Sevoflurane.

Simeprevir


The metabolism of Pentoxifylline can be decreased when combined with Simeprevir.

Spirapril


Pentoxifylline may increase the hypotensive activities of Spirapril.

Streptokinase


Pentoxifylline may increase the anticoagulant activities of Streptokinase.

Talinolol


Pentoxifylline may increase the hypotensive activities of Talinolol.

Telmisartan


Pentoxifylline may increase the hypotensive activities of Telmisartan.

Tenecteplase


Pentoxifylline may increase the anticoagulant activities of Tenecteplase.

Tenofovir Disoproxil


The metabolism of Pentoxifylline can be decreased when combined with Tenofovir disoproxil.

Teriflunomide


The serum concentration of Pentoxifylline can be decreased when it is combined with Teriflunomide.

Terlipressin


Pentoxifylline may increase the hypotensive activities of Terlipressin.

Theodrenaline


Pentoxifylline may increase the hypotensive activities of Theodrenaline.

Theophylline


The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.

Theophylline anhydrous


The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.

Tibolone


Pentoxifylline may increase the hypotensive activities of Tibolone.

Ticagrelor


Pentoxifylline may increase the antiplatelet activities of Ticagrelor.

Ticlopidine


Pentoxifylline may increase the antiplatelet activities of Ticlopidine.

Timolol


Pentoxifylline may increase the hypotensive activities of Timolol.

Timolol Anhydrous


Pentoxifylline may increase the hypotensive activities of Timolol.

Tinzaparin


Pentoxifylline may increase the anticoagulant activities of Tinzaparin.

Tinzaparin sodium


Pentoxifylline may increase the anticoagulant activities of Tinzaparin.

Tipranavir


Tipranavir may increase the antiplatelet activities of Pentoxifylline.

Tirofiban


Pentoxifylline may increase the antiplatelet activities of Tirofiban.

Tizanidine


The serum concentration of Tizanidine can be increased when it is combined with Pentoxifylline.

Tolazoline


Pentoxifylline may increase the hypotensive activities of Tolazoline.

Torsemide


Pentoxifylline may increase the hypotensive activities of Torasemide.

Tositumomab


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Tositumomab.

Trandolapril


Pentoxifylline may increase the hypotensive activities of Trandolapril.

Tranilast


Pentoxifylline may increase the antiplatelet activities of Tranilast.

Trapidil


Pentoxifylline may increase the antiplatelet activities of Trapidil.

Travoprost


Pentoxifylline may increase the hypotensive activities of Travoprost.

Treprostinil


Pentoxifylline may increase the hypotensive activities of Treprostinil.

Trichlormethiazide


Pentoxifylline may increase the hypotensive activities of Trichlormethiazide.

Triflusal


Pentoxifylline may increase the antiplatelet activities of Triflusal.

Trimethaphan


Pentoxifylline may increase the hypotensive activities of Trimethaphan.

Trolamine Salicylate


The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Trolamine salicylate.

Troxerutin


Pentoxifylline may increase the anticoagulant activities of Troxerutin.

UNOPROSTONE


Pentoxifylline may increase the hypotensive activities of Unoprostone.

Urapidil


Pentoxifylline may increase the hypotensive activities of Urapidil.

Urokinase


Pentoxifylline may increase the anticoagulant activities of Urokinase.

Valsartan


Pentoxifylline may increase the hypotensive activities of Valsartan.

Vemurafenib


The serum concentration of Pentoxifylline can be increased when it is combined with Vemurafenib.

Vincamine


Pentoxifylline may increase the hypotensive activities of Vincamine.

Vinpocetine


Pentoxifylline may increase the hypotensive activities of Vinpocetine.

Vitamin E


Vitamin E may increase the antiplatelet activities of Pentoxifylline.

Vorapaxar


Pentoxifylline may increase the antiplatelet activities of Vorapaxar.

Warfarin


Pentoxifylline may increase the anticoagulant activities of Warfarin.

Xylometazoline


Pentoxifylline may increase the hypotensive activities of Xylometazoline.

Zofenopril


Pentoxifylline may increase the hypotensive activities of Zofenopril.

Advertisement
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
How to Live Longer and Healthier: Secrets of Longevity Revealed
Stay Connected
Available on the Android Market Available on the App Store

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional